Patient Benefits
The TMRC provides new impetus for Scotland to lead the world in the development of personalised medicine, bringing new treatments to patients suffering from a range of serious illnesses.
The study and trial of biomarkers developed through the TMRC will enhance our understanding of disease and provide new diagnostic tests of disease.
Biomarkers can help to develop new treatments. The TMRC will include them in specialised clinical trials in Scotland working with the established network of doctors and researchers who conduct medical research to the highest ethical standards, whilst protecting patient confidentiality. These trials accelerate the process of getting new treatments from the laboratory to patients in the clinic, with the potential to enhance patient care and treatments. It will also help adapt prescription drugs to individual needs so that doctors can discover which groups of patients respond best to which medicines, enabling resources to be targeted more effectively, and making sure that the right patients get the right treatments.
The study and trial of biomarkers developed through the TMRC will enhance our understanding of disease and provide new diagnostic tests of disease.
Biomarkers can help to develop new treatments. The TMRC will include them in specialised clinical trials in Scotland working with the established network of doctors and researchers who conduct medical research to the highest ethical standards, whilst protecting patient confidentiality. These trials accelerate the process of getting new treatments from the laboratory to patients in the clinic, with the potential to enhance patient care and treatments. It will also help adapt prescription drugs to individual needs so that doctors can discover which groups of patients respond best to which medicines, enabling resources to be targeted more effectively, and making sure that the right patients get the right treatments.